کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5120750 1486261 2017 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Economic consequences of legal and illegal drugs: The case of social costs in Belgium
ترجمه فارسی عنوان
پیامدهای اقتصادی داروهای قانونی و غیرقانونی: مورد هزینه های اجتماعی در بلژیک
کلمات کلیدی
سیاست مواد مخدر، هزینه اجتماعی، داروهای غیر قانونی، داروهای قانونی، مراقبت های بهداشتی، اجرای قانون،
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی روانپزشکی و بهداشت روانی
چکیده انگلیسی

BackgroundLegal and illegal drugs impose a considerable burden to the individual and to society. The misuse of addictive substances results in healthcare and law enforcement costs, loss of productivity and reduced quality of life.MethodsA social cost study was conducted to estimate the substance-attributable costs of alcohol, tobacco, illegal drugs and psychoactive medication to Belgian society in 2012. The cost-of-illness framework with prevalence-based and human capital approach was applied. Three cost components were considered: direct, indirect and intangible costs related to substance misuse.ResultsThe direct and indirect cost of addictive substances was estimated at 4.6 billion euros in Belgium (419 euros per capita or 1.19% of the GDP) and more than 515,000 healthy years are lost due to substance misuse. The Belgian social cost study reaffirms that alcohol and tobacco impose the highest cost to society compared to illegal drugs. Health problems are the main driver of the social cost of legal drugs. Law enforcement expenditure exceed the healthcare costs but only in the case of illegal drugs.ConclusionEstimating social costs of addictive substances is complex because it is difficult to determine to what extent the societal harm is caused by substances. It can be argued that social cost studies take only a 'snapshot' of the monetary consequences of substance misuse. Nevertheless, the current study offers the most comprehensive analysis thus far of the social costs of substance misuse in Belgium.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Drug Policy - Volume 44, June 2017, Pages 50-57
نویسندگان
, , , , , , ,